TABLE 8.

Summary of univariate sensitivity analysis results

Analysis	Results
Lower 95% CI (hazard ratio) for exacerbations and costs	Budesonide-formoterol dominates*
Upper 95% CI (hazard ratio) for exacerbations and costs	Equivalent
Cost of salmeterol-fluticasone reduced (assuming all 50/250 μg dose)	Budesonide-formoterol dominates
Minimum wage instead of average wage	Budesonide-formoterol dominates
Cost of hospitalization based on average cost of asthma-related admission	Budesonide-formoterol dominates

^*Dominates refers to a strategy that is more effective and less costly